Correspondence
Fatal Infection with Influenza A (H5N1) Virus in China
N Engl J Med 2006; 354:2731-2732June 22, 2006
- Article
To the Editor:
A 24-year-old man had pneumonia and respiratory distress in November 2003 and died four days after being hospitalized. Because the clinical manifestations were consistent with those of the severe acute respiratory syndrome (SARS) and occurred when sporadic cases of SARS were described in southern China,1 serum and lung tissue from the patient, as well as fluid aspirated from his chest, were examined for SARS coronavirus with the use of indirect fluorescence antibody tests and the reverse-transcriptase polymerase chain reaction (RT-PCR). All tests were negative for SARS.
A virus was isolated from the lung tissue in Vero-cell cultures and was characteristic of influenza A virus on electron microscopy. A serum sample collected on day 8 of the patient's illness was positive for IgM antibody against the isolated virus. Fragments of both the influenza A virus matrix gene (M) and the H5-subtype hemagglutinin gene (HA) were amplified from the infected Vero cells with the use of RT-PCR assay.2,3 The nucleotide sequences of the fragments were identical to those amplified from the stored specimens of the patient's serum, chest fluid, and lung tissue.
The genomic sequence of the virus (A/Beijing/01/2003) was determined, and its eight segments were genetically related most closely to corresponding sequences of influenza A (H5N1) viruses that had been isolated from chickens in various regions of China in 2004. The segments of the polymerase basic protein 1 gene (PB) and the nonstructural gene (NS) were most closely related to those from Guangdong Province (in southeastern China), with 99 percent identity. The segments of the polymerase basic protein 2 gene (PB2) and HA gene were closest to those from Jilin Province (in northeastern China), with 99 percent and 97 percent identity, respectively. The segments of the neuraminidase gene (NA), nucleoprotein gene (NP), and M gene were closest to those from Hubei Province (in mideastern China), with 98 percent, 98 percent, and 99 percent identity, respectively, and the polymerase acidic protein gene (PA) segment was closest to that from Japan, with 99 percent identity.
These findings suggest that influenza A/Beijing/01/2003 may be a mixed virus. Phylogenetic analyses of the HA and NA genes of the representative influenza A (H5N1) strains have revealed that the viruses isolated from patients in Thailand and Vietnam in 2004 and 2005 belong to the same clade, and those obtained from patients in Hong Kong in 1997 and 1998 are from another clade (Figure 1 in the Supplementary Appendix, available with the full text of this letter at www.nejm.org). A sample of virus obtained from a patient in Hong Kong in 2003 seems to represent a transitional genotype, of which the HA gene sequence was close to the cluster from southeastern Asia (Figure 1A in the Supplementary Appendix), whereas the NA gene sequence was close to that of the cluster from Hong Kong in 1997 and 1998 (Figure 1B in the Supplementary Appendix). Phylogenetic analyses of the HA or NA gene indicated that the influenza A/Beijing/01/2003 strain was genetically distant from viruses previously isolated from humans, although it appears to have originated from a lineage similar to the influenza A/goose/Guangdong/1/96 (Gs/GD) lineage.4
These findings have important implications for selecting viruses for the development of vaccines to prevent infection in humans. The genetic distance between the isolate reported and the strain currently proposed for vaccine development (A/Vietnam/1203/2004)5 implies that viruses from different regions may need to be considered in the development of an effective vaccine against influenza A virus.
Qing-Yu Zhu, M.D.
State Key Laboratory of Pathogens and Biosecurity, Beijing 100071, ChinaE-De Qin, M.D.
Beijing Institute of Microbiology and Epidemiology, Beijing 100071, ChinaWei Wang, M.D.
309th Hospital of the People's Liberation Army, Beijing 100091, ChinaJun Yu, Ph.D.
Beijing Genomics Institute, Beijing 101300, ChinaBo-Hua Liu, Ph.D.
State Key Laboratory of Pathogens and Biosecurity, Beijing 100071, ChinaYi Hu, Ph.D.
Beijing Institute of Microbiology and Epidemiology, Beijing 100071, ChinaJian-Fei Hu, Ph.D.
Beijing Genomics Institute, Beijing 101300, ChinaWu-Chun Cao, M.D., Ph.D.
State Key Laboratory of Pathogens and Biosecurity, Beijing 100071, China
caowc@nic.bmi. ac. cn Supported by grants from the National Task Force of China (2004BA519A62 and 2004BA519A71) and the 973 High-Tech Projects Plan (2005CB52300015).
5 References1
Liang G ,Chen Q ,Xu J , et al. Laboratory diagnosis of four recent sporadic cases of community-acquired SARS, Guangdong Province, China. Emerg Infect Dis 2004;10:1774-1781
Web of Science | Medline2
Poddar SK . Influenza virus types and subtypes detection by single step single tube multiplex reverse transcription-polymerase chain reaction (RT-PCR) and agarose gel electrophoresis. J Virol Methods 2002;99:63-70
CrossRef | Web of Science | Medline3
Lee MS ,Chang PC ,Shien JH ,Cheng MC ,Shieh HK . Identification and subtyping of avian influenza viruses by reverse transcription-PCR. J Virol Methods 2001;97:13-22
CrossRef | Web of Science | Medline4
Chen H ,Smith GJD ,Li KS , et al. Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc Natl Acad Sci U S A 2006;103:2845-2850
CrossRef | Web of Science | Medline5
Treanor JJ ,Campbell JD ,Zangwill KM ,Rowe T ,Wolff M . Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 2006;354:1343-1351
Full Text | Web of Science | Medline
- Citing Articles (13)
Citing Articles
1
J. R. C. Pulliam, J. H. Epstein, J. Dushoff, S. A. Rahman, M. Bunning, A. A. Jamaluddin, A. D. Hyatt, H. E. Field, A. P. Dobson, P. Daszak, . (2011) Agricultural intensification, priming for persistence and the emergence of Nipah virus: a lethal bat-borne zoonosis. Journal of The Royal Society Interface
CrossRef2
ChunXiang Cao, Min Xu, ChaoYi Chang, Yong Xue, ShaoBo Zhong, LiQun Fang, WuChun Cao, Hao Zhang, MengXu Gao, QiSheng He, Jian Zhao, Wei Chen, Sheng Zheng, XiaoWen Li. (2010) Risk analysis for the highly pathogenic avian influenza in Mainland China using meta-modeling. Chinese Science Bulletin 55:36, 4168-4178
CrossRef3
Di Liu, XiaoLing Liu, JingHua Yan, Wen-Jun Liu, George Fu Gao. (2009) Interspecies transmission and host restriction of avian H5N1 influenza virus. Science in China Series C: Life Sciences 52:5, 428-438
CrossRef4
Zheng Kou, FuMin Lei, ShengYue Wang, YanHong Zhou, TianXian Li. (2008) Molecular patterns of avian influenza A viruses. Chinese Science Bulletin 53:13, 2002-2007
CrossRef5
Joyshri Sarangi, Chloe Sellwood, Jonathan S. Nguyen-Van-Tam. (2008) Responding to bird influenza: Past, present and future. Travel Medicine and Infectious Disease 6:4, 190-194
CrossRef6
Matthew Smallman-Raynor, Andrew D. Cliff. (2008) The Geographical Spread of Avian Influenza A (H5N1): Panzootic Transmission (December 2003–May 2006), Pandemic Potential, and Implications. Annals of the Association of American Geographers 98:3, 553-582
CrossRef7
Timothy M. UYEKI. (2008) Global epidemiology of human infections with highly pathogenic avian influenza A (H5N1) viruses. Respirology 13:s1, S2-S9
CrossRef8
Hana M El Sahly, Wendy A Keitel. (2008) Pandemic H5N1 influenza vaccine development: an update. Expert Review of Vaccines 7:2, 241-247
CrossRef9
Stephen S Morse. (2007) The US pandemic influenza implementation plan at six months. Nature Medicine 13:6, 681-684
CrossRef10
Jonathan S. Nguyen-Van-Tam, Chloe Sellwood. (2007) Avian influenza and the threat of the next human pandemic. Journal of Hospital Infection 65, 10-13
CrossRef11
Yaseen Arabi, Charles D. Gomersall, Qanta A. Ahmed, Bruce R. Boynton, Ziad A. Memish. (2007) The critically ill avian influenza A (H5N1) patient*. Critical Care Medicine 35:5, 1397-1403
CrossRef12
Alan W Hampson. (2006) Avian influenza: A pandemic waiting in the wings?. Emergency Medicine Australasia 18:5-6, 420-429
CrossRef13
(2006) News In brief. Nature Medicine 12:9, 984-985
CrossRef
